uniQure基因治疗

US · QURE #2954 按市值排名上市于 1970

21.78 -0.74 -3.29%

实时 - 追踪5344个代码 - 心跳于8秒前 · 2026-10-16 20:02

✦ 量化股权信号计算方式说明

减持

最近一期（2026/Q3）披露持股的机构数量减少了3家。
机构持股总比例下降了0.9个百分点。

机构持股

机构持股比例: 96.79% -0.92pp
机构数量: 298 -3
数据截至: 2026/Q3 较上一报告期

持股变动 vs 资金流向

方向一致

机构在上一报告期减持了股份，同时该股在最近20个交易日的主力资金呈净流出——两者方向一致。

机构持股变动数据按季度发布且存在滞后；资金流向数据为每日更新。请将其作为方向性的交叉验证参考，而非精确的择时信号。

持股人类型

Hedge Fund42.05%

Mutual Fund38.14%

VC/PE Fund6.06%

Private Company4.89%

Public Company4.76%

Individual/Insider1.69%

Government Pension Fund0.52%

Family Office/Trust0.27%

Insurance Company0.11%

Other1.52%

主要股东截至 2026-06-30

Avoro Capital Advisors LLC 9.70% · 6.73M 股

J.P. Morgan Asset Management, Inc. 6.81% · 4.73M 股

RTW Investments, LP 5.68% · 3.94M 股

State Street Global Advisors 4.19% · 2.90M 股

abrdn plc 4.11% · 2.85M 股

BlackRock 2.71% · 1.88M 股

OrbiMed Advisors LLC 2.61% · 1.81M 股

Jane Street Group, LLC 2.32% · 1.61M 股

Jennison Associates LLC 2.25% · 1.56M 股

Boxer Capital Management, LLC 2.17% · 1.50M 股

条形长度是相对于此处列出的最大股东而言，并非相对于公司100%股权。

内部人持股

共追踪50份申报 · 19次买入 · 31次卖出

姓名	职务	持股比例
Matthew Kapusta	Chief Executive Officer	0.75%
Walid Abi-Saab	Chief Medical Officer	0.21%
Christian Klemt	CFO, Principal Financial Officer & GM of Amsterdam Site	0.18%
Kylie O'Keefe	Chief Customer & Strategy Officer	0.16%
Jeannette Potts	Chief Legal & Compliance Officer	0.08%
Madhavan Balachandran	Independent Non-Executive Director	0.06%
Jeremy Springhorn	Independent Non-Executive Director	0.05%
David Meek	Independent Chairperson	0.05%
Leonard Post	Independent Non-Executive Director	0.04%
Rachelle Jacques	Non-Executive Director	0.04%

内部人交易最近的 Form 4 申报记录

日期	姓名	职务	类型	股数	价格
2026-07-01	Matthew Kapusta	Chief Executive Officer	Derivative Exercise and Sale	-21,082	$19.39–45.89
2026-06-29	Jack Kaye	Independent Non-Executive Director	Derivative Exercise and Sale	-21,167	$20.18–46.49
2026-06-29	Walid Abi-Saab	Chief Medical Officer	Automatic Disposition	-20,000	$46.40
2026-06-29	Walid Abi-Saab	Chief Medical Officer	Derivative Exercise and Sale	-10,000	$5.59–46.46
2026-06-25	Walid Abi-Saab	Chief Medical Officer	Open Market Disposition	-1,434	$46.86
2026-06-24	Matthew Kapusta	Chief Executive Officer	Derivative Exercise and Sale	-32,844	$31.71–50.02
2026-06-24	Matthew Kapusta	Chief Executive Officer	Intent to Sell (Form 144)	-28,716	$50.02
2026-06-23	Matthew Kapusta	Chief Executive Officer	Automatic Disposition	-2,568	$50.00
2026-06-17	Matthew Kapusta	Chief Executive Officer	Automatic Disposition	-138,863	$43.43–50.00
2026-06-17	Matthew Kapusta	Chief Executive Officer	Derivative Exercise and Sale	-67,237	$19.39–50.00
2026-06-17	Matthew Kapusta	Chief Executive Officer	Intent to Sell (Form 144)	-41,671	$46.38
2026-06-16	Matthew Kapusta	Chief Executive Officer	Intent to Sell (Form 144)	-164,429	$43.00
2026-06-16	Jack Kaye	Independent Non-Executive Director	Derivative Exercise and Sale	-5,295	$31.71–42.57
2026-06-16	Madhavan Balachandran	Independent Non-Executive Director	Derivative Exercise and Sale	-11,685	$19.39–47.08
2026-06-14	Madhavan Balachandran	Independent Non-Executive Director	Derivative Exercise and Sale	-10,000	$8.49–27.85
2026-06-14	Jeannette Potts	Chief Legal & Compliance Officer	Open Market Disposition	-5,237	$27.67
2026-06-10	Leonard Post	Independent Non-Executive Director	Open Market Disposition	-1,993	$27.06
2026-06-10	Jack Kaye	Independent Non-Executive Director	Open Market Disposition	-1,993	$27.06
2026-06-10	Madhavan Balachandran	Independent Non-Executive Director	Open Market Disposition	-1,993	$27.06
2026-06-10	Jeremy Springhorn	Independent Non-Executive Director	Open Market Disposition	-1,993	$27.06

Form 4 申报记录，每家公司显示最新的一批。"Other Derivative Acquisition"（其他衍生品获取）类目多为限制性股票/期权归属，并非公开市场买入——具体类型见"类型"列。

报价时间 2026-10-16 20:02:11 · 仅供参考，不构成投资建议，也未考虑您的具体情况。